NovaMedica is a new kind of pharmaceutical company. Our strategy is to search the world for important new approved products that will help improve the health care of Russians, in addition to the exciting line of pipeline products we will in-license from the portfolio companies of Domain Associates in which our shareholders choose to invest. We will bring these products to Russia and the CIS countries and then market them to Russian/CIS specialty physicians and health care providers better than anyone else. As part of our mission to be a leading provider in Russia and the CIS of innovative specialty pharma products and solutions that treat a range of therapeutic disorders, we will be developing this site over the coming months to provide Russian and CIS healthcare professionals with an assortment of educational and information resources.
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem (World Health Organization).
Please inform us of any adverse events that might be associated with our pharmaceutical products:
· via the hotline: +7 (800) 222-49-08
· by e-mail:
Pharmaceutical safety information is extremely important as it helps ensure that medicinal products are being used in an effective and safe manner.
Russia has eliminated the shortage of therapies for epilepsy and thyroid diseases
23 May 2022
FDA Publishes Draft Guidance on Quality Assessments
23 May 2022
New polymer coating for improved cancer targeting of nanomedicine
20 May 2022
Preparation is key: the role of scientific due diligence in successful partnerships
20 May 2022